Clinical Trial Update: Immunogenicity and Safety of the Yellow Fever Vaccine in HIV Infected Individuals [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update assessing the immunogenicity and safety of the yellow fever vaccine in individuals infected with HIV.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Yellow fever vaccine (live attenuated yellow fever vaccine)

Snippet

Sponsor: Oswaldo Cruz Foundation | Conditions: HIV Infections | Phase 4 | Status: RECRUITING